Philippines Dialysis Market Outlook to 2027

Market Overview:

The Philippines Dialysis Market is anticipated to witness tremendous growth owing to factors affecting markets including the increasing prevalence of CKD in the Philippines, the Aging Population, Government funding, and Technological Development. The market is considered highly consolidated with the global players dominating the market with more than 80% of the market share alongside the presence of small domestic players.

The Philippines Dialysis market has been evolving consistently over the years and is expected to maintain the same growth in the forecasted period as well supported by the Implementation of Universal healthcare coverage. In 2021, the Philippines was nominated as the third-largest pharmaceutical market in ASEAN after Indonesia and Thailand. Global manufacturers of dialysis consumables and equipment such as Fresenius and Bbraun are dominating the market followed by Nikkiso and others.

The Dialysis market in the Philippines is distinguished by consolidation with the presence of major global players like Fresenius, Bbraun, Nikkiso, Nipro, and Toray along with small domestic companies. Approximately, 98% of the market is occupied by the top seven players with Fresenius and Bbrauan holding the maximum share. At the moment industry is growing consistently and is predicted to maintain this trend in the medium to long term.

Philippines Dialysis Market Analysis

• Global manufacturers of dialysis consumables and equipment including Fresenius, Bbraun, Nikkiso, Nipro, and Toray have strong presence in the Philippines dialysis market.
• According to the Philippines' Renal Disease Registry, 21,535 people had dialysis in 2016, a significant increase from the 10,000 cases recorded in 2010.
• In terms of gender, there are 27,773 male dialysis patients and 18,515 female patients in 2022, making up a 60% to 40% ratio.
• In 2022, About 46,288 individuals underwent dialysis therapy out of which are the high-income group is leading the market followed by the middle-income group, and the low-income group.
• Private institutions have 481 dialysis centers in the country which is 98.2% of the total market. Private institutions have greater financial sources and investments compared to government organizations which enables them to establish modern and advanced dialysis centers in the country.
• According to a report issued by Insights10 in 2021, the Philippines' dialysis market is expected to grow positively as a result of the increasing prevalence of diabetes, which initially affects kidney function.

Key Trends by Market Segment:

By Type of Dialysis Center: ThePhilippines dialysis market issegmentedby type of dialysis centers into two categories- Dialysis Consumables and Dialysis Equipment.  Dialysis Consumables are dominating the market with approximately 75% of the market share. Dialysis supplies and equipment sales are being driven by the rise in patients with acute kidney illness, diabetes, and hypertension in the Philippines. The nation's expanding healthcare system is also providing businesses that manufacture and sell dialysis supplies and equipment with enormous financial opportunities.

By Type of Gender: In 2022, the Philippines Dialysis Market is predominated by male dialysis patients as they account for more than 50% of the overall dialysis market. Their lifestyle choices, which include drinking alcohol, smoking, and following certain dietary guidelines that raise the risk of renal disease, are a major contributing factor to the larger male proportion among dialysis patients. Comparatively, Kidney diseases progress more slowly in women because they are more likely to seek medical assistance earlier or to engage in preventative healthcare activities.

By Type of Income Level: On the income levelthe Philippines Dialysis Market is segmentedinto three categoriesHigh income, Middle income, and Low income. Middle-income group is dominating the market with approximately 50% of the market share followed by High-income and Low-income groups. Individuals with higher incomes are more likely to have full coverage for health insurance. Those with higher earnings find dialysis treatments much cheaper if they have health insurance. They can afford private medical facilities with cutting-edge dialysis procedures and technology.

Competitive Landscape:

Major Players in The Philippines Dialysis Market

• It is thought that the Philippine dialysis market is extremely consolidated due to the dominance of international producers of dialysis supplies and equipment as well as the entry of new domestic competitors.
• Top players include Fresenius, the leading distributor with well over 50% of the market as of 2022, and B Braun, a significant manufacturer and distributor. Nikkiso, Nipro, Toray, Gambro, and Others are also holding significant positions in the market.
• Among the significant Dialysis Centers in the Asia Pacific, Fresenius Medical Care operates a network of about 400 dialysis facilities that provide care for over 30,000 patients annually.
• The country's growing healthcare infrastructure is also opening up immense earning potential for companies that produce and distribute dialysis supplies and equipment in the country.
• National Kidney and Transplant Institution is one of the country’s top institutes for the operations of dialysis treatment in the Philippines.

Recent Developments:

• In 2019, the government of the Philippines introduced the UHC (Universal Healthcare Act) No.11223. This law guarantees free access to quality healthcare services for all Filipinos which includes treatment for rare diseases. In the first year after the passage of the UHC law, PhilHealth covers up to 156 sessions per year for patients.
• In October 2020, NephroPlus acquired a 51% share in Royal Care dialysis centers in the Philippines. The company aims to become the largest dialysis network in the country within the next five years.
• In October 2019, Medline, a dominant dialysis chain operator in the Philippines to provide Filipinos with improved access to reasonably priced dialysis treatment, MedLine obtained funding from ARQCapital for the construction of standalone dialysis centers in strategic locations throughout the nation.

Future Outlook:

• The market will grow at a CAGR of 19.6% during 2022-2027 owing to factors such as the prevalence of CKD in the Philippines, the Aging Population, Government funding, and Technological Development.
• The Philippines' high rate of chronic kidney disease (CKD) is a result of the dialysis population's remarkable growth during the previous ten years.
• Government support for end-stage renal disease (ESRD) therapy is also driving the expansion of dialysis clinics in developing nations. The Philippines issued a national policy for renal dialysis in 2014, indicating a commitment to improving access to dialysis treatment.
• The development of more portable and efficient dialysis equipment, better dialysis membranes, and remote monitoring systems are just a few examples of the technological advances that will impact dialysis in the Philippines and other nations in the future.